Budget
NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. The scope of the NIAID research portfolio has expanded considerably in recent years in response to new challenges such as bioterrorism, emerging and re-emerging infectious diseases, and the increase in asthma prevalence among children in this country.
The growth of NIAID programs has also been driven by unprecedented scientific opportunities in the core NIAID scientific disciplines of microbiology, immunology, and infectious diseases. Advances in these key fields have led to a better understanding of the human immune system and the mechanisms of infectious and immune-mediated diseases.
FY 2009 Budget
Justification Narrative for FY 2009 President's Budget for NIAID (PDF)
FY 2008 Budget
Justification Narrative for FY 2008 President's Budget for NIAID (PDF)
FY 2007 Budget
Organization chart (PDF)
Appropriation language (PDF)
Amounts available for obligation (PDF)
Justification narrative (PDF)
Budget mechanism table (PDF)
Budget authority by activity (PDF)
Summary of changes (PDF)
Budget authority by object (PDF)
Salaries and expenses (PDF)
Significant items in House and Senate Appropriations Committee Reports (PDF)
Authorizing legislation (PDF)
Appropriations history (PDF)
Detail of full-time equivalent employment (FTEs) (PDF)
Detail of positions (PDF)
New positions requested (PDF)
back to top